Company Number: 13438936

Analysis Date: 2025-07-20 17:16 UTC

Financial Health Assessment for JAN MAYEN LIMITED

---

1. Financial Health Score: Grade D

Explanation:
JAN MAYEN LIMITED is currently classified as a dormant company with minimal financial activity over multiple years. Its financial "vital signs" indicate no operational revenue, expenses, or business transactions beyond the initial share capital of £100. While this status means the company is not exhibiting symptoms of financial distress, it equally shows no signs of business growth or active trading, which limits the potential for financial health improvement or sustainability as an ongoing business. Hence, this company is graded as D — neither ill nor thriving, but essentially inactive.

---

2. Key Vital Signs

Metric	Latest Value (2024)	Interpretation
Cash at Bank	£100	Extremely low cash reserves; reflects no trading activity
Net Assets	£100	Equal to the minimal share capital; no retained earnings
Shareholders’ Funds	£100	Entirely composed of initial share capital; no profits or losses
Account Status	Dormant	No significant financial transactions in the year
Filing Compliance	Up to date	Accounts and annual returns filed on time; no penalties

Interpretation of Vital Signs:

• The company's balance sheet is effectively static, indicating a "heart rate" of zero business activity.
• No liabilities or assets beyond the initial capital suggest no financial operational stress but also no growth or revenue generation.
• Compliance with filing deadlines suggests healthy administrative functioning despite dormancy.

---

3. Diagnosis

Underlying Business Health:
JAN MAYEN LIMITED currently exhibits the financial profile of a "patient" in a medically dormant state — akin to a patient in deep rest or hibernation. There are no symptoms of distress such as debt accumulation, cash flow problems, or shareholder equity erosion. However, the absence of business activity means the company is not generating income or value, which is a symptom of inactivity rather than poor health.

Risks and Considerations:

• Prolonged dormancy may lead to business irrelevance or loss of market opportunities.
• Without active cash flow or operational metrics, the company's financial prognosis depends entirely on future business decisions.
• The recent resignation of the sole director may signal upcoming changes or potential closure, which should be monitored.

---

4. Recommendations

To transition from dormancy towards financial wellness and operational vitality:

1. Strategic Review:
   Evaluate the business purpose and market potential. Determine if the company should be reactivated, sold, or formally closed to avoid ongoing compliance costs.

2. Director Appointment:
   Given the resignation of the sole director, promptly appoint a new director to ensure legal compliance and governance continuity.

3. Capital Injection & Planning:
   If reactivation is intended, plan for initial funding to support operational costs and working capital. Develop a basic budget and cash flow forecast to monitor future financial health.

4. Regular Financial Monitoring:
   Once active, implement routine financial reviews focusing on cash flow, profitability, and asset management to detect any early symptoms of financial distress.

5. Compliance Maintenance:
   Continue timely filing of accounts and confirmation statements to maintain good standing and avoid penalties.

---